John Neylan

John Neylan

Chief Tech/Sci/R&D Officer at AKARI THERAPEUTICS, PLC
72 year
Health Technology
Consumer Services
Commercial Services

Profile

John F.
Neylan
is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.

John Neylan active positions

CompaniesPositionStart
AKARI THERAPEUTICS, PLC Chief Tech/Sci/R&D Officer 08/11/2022

Former positions of John Neylan

CompaniesPositionEnd
ANGN BIOM Chief Tech/Sci/R&D Officer 15/08/2022
KERYX BIOPHARMACEUTICALS Chief Tech/Sci/R&D Officer 12/12/2018
Corporate Officer/Principal 01/05/2008
Director/Board Member -
President -
See the detail of John Neylan's experience

Training of John Neylan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology